ClearView Convos Episode 6: Advancing Roles of Bispecific T-Cell Engagers and CAR T

In this episode of ClearView Convos, Sam Ulin is joined by Kelsey Yardumian and David Konciak to unpack the evolving landscape of cell therapies. With multiple approvals in hematologic malignancies, both modalities are redefining the oncology landscape—but diverge in key ways that impact clinical strategy, patient access, and commercialization.